Brain scans reveal how stuttering works in new drug study

NCT ID NCT07215884

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study gives aripiprazole, a drug that affects dopamine, to 40 adults who stutter to see how it changes brain activity during speech. Researchers use brain scans and audio recordings to measure how the brain processes sound before and during speaking. The goal is to better understand the brain pathways involved in stuttering, not to test a treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STUTTERING, ADULT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

stutter disorder Stuttering

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Biomagentic Imaging Lab

    RECRUITING

    San Francisco, California, 94143, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact